Home / People / Dr. Susanne Pech

Dr. Susanne Pech


CMS Hasche Sigle
Stadthausbrücke 1-3
20355 Hamburg
Languages German, English

IP lawyer Susanne Pech mainly represents life sciences companies (pharmaceuticals, medical devices and food) but also businesses in other industries. She focuses on advisory work and litigation in unfair competition matters and cases related to the advertising of healthcare products (German Heilmittelwerberecht) as well as on product liability and pharmaceutical and medicinal products law. She is also experienced in food and feed law and product piracy matters.

Susanne joined CMS in 2015 from a major international law firm in Hamburg. In 2016, she was seconded to the legal department of an international medical device manufacturer. In 2017, she was seconded to the legal department of an international food company. She has been a counsel since 2020.

more less


  • 2013: PhD (Dr. iur.)
  • 2013: Second state examination in law
  • 2011 - 2013: Trainee lawyer in Hamburg, including a stage in Los Angeles
  • 2009: First state examination in law
  • 2004 - 2009: Law studies in Passau
more less


  • Sanctions of the EU motivated by foreign policy, studies and materials regarding public law, volume 42, Peter Lang, 2013.
more less


Show only
Apotal Group sells on­line phar­macy’s mail-or­der busi­ness and dia­betes arm...
Stut­tgart – Com­pany founder Heinz-Peter Fichter and oth­er share­hold­ers have sold the mail-or­der busi­ness of on­line phar­macy Apotal and its dia­betes di­vi­sion to the lis­ted Zur Rose Group of Switzer­land...
20 April 2020
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
In re­cent years can­nabis trade and re­lated activ­ity has de­veloped in­to a growth busi­ness area. In the life sci­ences and health­care fields there have been in­creases in the num­bers of pa­tients hav­ing ac­cess...
23 November 2020
EU high court con­firms CBD is not a nar­cot­ic
In a long-awaited rul­ing, the European Court of Justice (ECJ) cla­ri­fied that the can­nabis act­ive in­gredi­ent Can­na­bi­d­i­ol (CBD) is not to be clas­si­fied as a nar­cot­ic. France sub­mits ques­tion on CBD in e-ci­gar­ettes...